Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02635360
Recruitment Status : Active, not recruiting
First Posted : December 18, 2015
Last Update Posted : April 28, 2021
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Linda R Duska, University of Virginia

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : January 2021
Estimated Study Completion Date : December 2021